Phio Pharmaceuticals logo

Phio Pharmaceuticals

PHIO | NASDAQ
Chart Builder DCF Calculator
$0.75
-$0.02 (-2.72%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
+$0.02 (+2.80%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.72%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
29.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #812/1021 (Top 80%)

Key Statistics

Market Data

Market Cap $8.99M
1D Range
0.72 0.77
52W Range
0.72 1.65

Valuation (TTM)

PE -0.60
PB 1.04
EV/EBITDA 0.15

Valuation (NTM)

Forward PE N/A
Forward PEG 0.10
Price Target $14.00
Loading financial charts...

Profile

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designe...

Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date May 10, 2012
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$14.00
Upside
+1766.67%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.